- ￥2000 - 4000
- Sino Biological
- 北京
- 40588-R0004
- 2025年10月10日
- WB,ELISA
- Rabbit
- 2019-nCoV
企业认证
研选同类产品更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 用户评价
- 文献和实验
- 技术资料
- 免疫原：
Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (Catalog#40588-V08B)
- 亚型：
Rabbit IgG
- 形态：
液体
- 保存条件：
-20℃ 至 -80℃
- 克隆性：
单克隆
- 标记物：
无
- 适应物种：
2019-nCoV
- 保质期：
12个月
- 抗原来源：
40588-V08B
- 目录编号：
40588-R0004
- 级别：
免疫学试剂
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 宿主：
Rabbit
- 应用范围：
WB,ELISA
- 浓度：
WB: 1:500-1:2000;ELISA: 1:5000-1:10000
- 靶点：
NP-CoV
- 抗体英文名：
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb
- 抗体名：
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb
- 规格：
100 µL/20 µL
| 规格： | 100 µL | 产品价格： | ￥4000.0 |
|---|---|---|---|
| 规格： | 20 µL | 产品价格： | ￥2000.0 |
Coronavirus Nucleocapsid|Coronavirus Nucleocapsid antibody|Coronavirus Nucleocapsid抗体|Anti-2019-nCoV 兔单抗（产品说明）
抗体种属：2019-nCoV
抗体靶点：NP-CoV
抗体应用：WB,ELISA
抗原货号：40588-V08B
抗原描述：Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (Catalog#40588-V08B)
抗体宿主：Rabbit
抗体Ig类型：Rabbit IgG
抗体纯化方法：Protein A
抗体制备：This product is a recombinant monoclonal antibody expressed from HEK293 cells.
抗体特异性：SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein
抗体保存：This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
用户评价
暂无用户评价
文献和实验1, Agarwal DK, et al. Highly sensitive and ultra-rapid antigen-based detection of SARS-CoV-2 using nanomechanical sensor platform.Biosensors & bioelectronics, PubMed ID: 34583103
2, Yang M, et al. Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity.Signal transduction and targeted therapy, PubMed ID: 38355661
Establishment and Characterization of Monoclonal Antibodies Against SARS Coronavirus
against severe acute respiratory syndrome coronavirus (SARS-CoV). B cell hybridomas are generated from mice that are hyperimmunized with inactivated SARS-CoV virions. The hybridomas produce monoclonal antibodies that recognize viral component molecules, including
Molecular Diagnosis of Severe Acute Respiratory Syndrome
The etiologic agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, known as SARS-coronavirus (SARS-CoV). Although the SARS epidemic has subsided, many authorities, including the World Health
